New Zealand markets closed

ABVC BioPharma, Inc. (ABVC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.08000.0000 (0.00%)
At close: 04:00PM EDT
1.0600 -0.02 (-1.85%)
After hours: 07:56PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 11.51M
Enterprise value 13.65M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)31.00
Price/book (mrq)1.37
Enterprise value/revenue 89.55
Enterprise value/EBITDA -1.68

Trading information

Stock price history

Beta (5Y monthly) 0.77
52-week change 3-88.26%
S&P500 52-week change 324.49%
52-week high 39.6000
52-week low 30.6740
50-day moving average 31.2067
200-day moving average 31.4103

Share statistics

Avg vol (3-month) 31.16M
Avg vol (10-day) 32.74M
Shares outstanding 510.56M
Implied shares outstanding 610.56M
Float 86.8M
% held by insiders 126.97%
% held by institutions 14.12%
Shares short (15 Apr 2024) 4532.98k
Short ratio (15 Apr 2024) 40.31
Short % of float (15 Apr 2024) 46.91%
Short % of shares outstanding (15 Apr 2024) 45.05%
Shares short (prior month 15 Mar 2024) 4105.84k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 308 May 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 325 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-90,605.55%

Management effectiveness

Return on assets (ttm)-42.67%
Return on equity (ttm)-191.96%

Income statement

Revenue (ttm)152.43k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)-99.60%
Gross profit (ttm)N/A
EBITDA -8.19M
Net income avi to common (ttm)-10.52M
Diluted EPS (ttm)-2.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)139.47k
Total cash per share (mrq)0.01
Total debt (mrq)2.45M
Total debt/equity (mrq)30.13%
Current ratio (mrq)0.28
Book value per share (mrq)1.06

Cash flow statement

Operating cash flow (ttm)-4.24M
Levered free cash flow (ttm)-2.77M